Genpact Limited (NYSE:G – Get Free Report) has earned a consensus recommendation of “Hold” from the nine research firms that are presently covering the firm, MarketBeat reports. Eight equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.33.
A number of research firms recently commented on G. Needham & Company LLC lifted their target price on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th. TD Cowen raised their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research report on Friday, November 8th. Finally, Robert W. Baird upped their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 8th.
View Our Latest Stock Analysis on Genpact
Genpact Stock Performance
Genpact Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, December 23rd. Stockholders of record on Monday, December 9th were issued a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.40%. The ex-dividend date was Monday, December 9th. Genpact’s dividend payout ratio (DPR) is 16.76%.
Insider Buying and Selling
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $11,926,218.40. This represents a 4.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Over the last three months, insiders have sold 23,058 shares of company stock valued at $1,044,715. Corporate insiders own 2.80% of the company’s stock.
Institutional Investors Weigh In On Genpact
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Natixis Advisors LLC grew its position in shares of Genpact by 2.9% in the second quarter. Natixis Advisors LLC now owns 111,132 shares of the business services provider’s stock valued at $3,577,000 after purchasing an additional 3,101 shares during the period. Custom Index Systems LLC acquired a new stake in Genpact in the 2nd quarter worth about $416,000. Caprock Group LLC purchased a new stake in Genpact during the 2nd quarter worth approximately $238,000. Ballentine Partners LLC increased its stake in Genpact by 22.0% during the 2nd quarter. Ballentine Partners LLC now owns 14,377 shares of the business services provider’s stock worth $463,000 after buying an additional 2,594 shares in the last quarter. Finally, United Services Automobile Association lifted its position in shares of Genpact by 3.3% in the second quarter. United Services Automobile Association now owns 13,388 shares of the business services provider’s stock valued at $431,000 after acquiring an additional 433 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- What is a Dividend King?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Financial Services Stocks Investing
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What Are Dividends? Buy the Best Dividend Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.